Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 38 | 0 | 0 | 0 | 0 |
| Gross Profit | 38 | N/A | N/A | N/A | N/A |
| Operating Expenses | 1,263 | 0 | 5,186 | 0 | 2,129 |
| Operating Income | -1,225 | -10,747 | -5,186 | N/A | -2,129 |
| Interest Expense | 2 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 10,747 | 2 | 0 | -18 |
| Pre-tax Income | -1,227 | 0 | -5,184 | 0 | -2,147 |
| Net Income Continuous | -1,227 | N/A | -5,184 | N/A | -2,147 |
| Net Income | $-1,227 | $N/A | $-5,184 | $N/A | $-2,147 |
| EPS Basic Total Ops | -72.00 | -624.00 | -304.00 | N/A | -696.00 |
| EPS Basic Continuous Ops | -70.33 | N/A | -299.51 | N/A | -295.80 |
| EPS Diluted Total Ops | -72.00 | -624.00 | -304.00 | N/A | -696.00 |
| EPS Diluted Continuous Ops | -70.33 | N/A | -299.51 | N/A | -295.80 |
| EBITDA(a) | $-1,086 | $40 | $-5,186 | $N/A | $-1,890 |